Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 9Other solid neoplasm 8Breast 6Sarcoma 5Dermatologic 4Plasma cell 2Other hematologic neoplasm 2Myeloid 2Genitourinary 2CNS 2Other neoplasm 1Lymphoid 1Head & Neck 1Classical hematology 1

Conditions

Rectal Neoplasms 1Precancerous Conditions 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Biopsy 4Cyclophosphamide 3Microarray Analysis 2Methylprednisolone 2Filgrastim 2Colposcopy 2Carboplatin 2toripalimab 1tipifarnib 1sargramostim 1sapanisertib 1pyroxamide 1pirfenidone 1penpulimab 1palbociclib 1liposomal doxorubicin 1iodixanol 1human papillomavirus vaccine, TA 1artemisinin 1arginine butyrate 1Zoledronic Acid 1Vincristine 1Video-Assisted Surgery 1Topotecan 1Tetradecanoylphorbol Acetate 1Taxes 1Tacrolimus 1Specimen Handling 1Sorafenib 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Celecoxib × Other neoplasm × Clear all
NCT00685568 2018-11-07

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

M.D. Anderson Cancer Center

Phase 1 Completed
22 enrolled
GastrointestinalOther neoplasm

Colonic Neoplasms, Adenomatous Polyposis Coli, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡